<b>Investigating the Role of Molecular Biology Techniques in Advancing Precision Medicine and Personalized Therapeutic Approaches for Human Diseases</b>
Bibliographic record
Abstract
Background: Precision medicine represents a transformative shift in healthcare, aiming to tailor diagnostic and therapeutic strategies to individual patient characteristics. This paradigm is critically dependent on advancements in molecular biology techniques, which provide the tools to decipher the genetic and molecular underpinnings of disease. Understanding the role and limitations of these technologies is essential for their effective integration into clinical practice. Objective: This narrative review aims to analyze the contemporary role of key molecular biology techniques in advancing precision medicine and fostering the development of personalized therapeutic approaches for a range of human diseases. Main Discussion Points: The review synthesizes evidence around several core themes. It examines how next-generation sequencing serves as a cornerstone for genomic diagnosis and patient stratification, particularly in oncology and rare genetic diseases. The application of liquid biopsies for minimally invasive disease monitoring and the detection of resistance mechanisms is discussed. Furthermore, the review explores the revolutionary potential of CRISPR-Cas9 gene editing as a curative therapeutic modality and considers the integrative power of multi-omics approaches for unraveling complex disease pathophysiology. Conclusion: Molecular biology techniques are indisputably central to the realization of precision medicine, enabling a move from empirical to mechanism-based healthcare. However, their full potential is currently constrained by challenges related to evidence generalizability, methodological standardization, and health equity. Future efforts must focus on rigorous clinical validation, the development of inclusive genomic databases, and the creation of supportive policy frameworks to ensure these powerful tools deliver equitable and improved health outcomes across diverse patient populations.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.015 | 0.023 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.002 |
| Bibliometrics | 0.002 | 0.003 |
| Science and technology studies | 0.001 | 0.005 |
| Scholarly communication | 0.009 | 0.008 |
| Open science | 0.002 | 0.004 |
| Research integrity | 0.006 | 0.006 |
| Insufficient payload (model declined to judge) | 0.043 | 0.015 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".